Evidence map›Paper›PMID 41742191›Full record

ArticleRespiratory research2026

Label-free optical fingerprints of hyperoxia-induced lung alterations in preterm rabbits.

Margherita Marazzini, Enrica Scalera, Simone De Meo, Francesca Ricci, Gino Villetti, Xabier Murgia, Matteo Zoboli, Ferdinando Gazza, Gianmarco Ferri, Francesco Cardarelli

Abstract read
In one paragraph

Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Margherita MarazziniNEST Laboratory-Scuola Normale Superiore, Pisa, Italy. margherita.marazzini@sns.it.
Enrica ScaleraDepartment of Experimental Pharmacology and Translational Science, R&D, Chiesi Farmaceutici S.p.A., Parma, Italy. e.scalera@chiesi.com.
Simone De MeoDepartment of Life Sciences, University of Siena, Siena, Italy.
Francesca RicciDepartment of Experimental Pharmacology and Translational Science, R&D, Chiesi Farmaceutici S.p.A., Parma, Italy.
Gino VillettiDepartment of Experimental Pharmacology and Translational Science, R&D, Chiesi Farmaceutici S.p.A., Parma, Italy.
Xabier MurgiaScientific Consultancy, Bilbao, Spain.
Matteo ZoboliDepartment of Veterinary Science, University of Parma, Parma, Italy.
Ferdinando GazzaDepartment of Veterinary Science, University of Parma, Parma, Italy.
Gianmarco FerriFondazione Pisana per la Scienza ONLUS, Pisa, Italy.
Francesco CardarelliNEST Laboratory-Scuola Normale Superiore, Pisa, Italy. francesco.cardarelli@sns.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBronchopulmonary dysplasia (BPD) is a chronic lung disease of preterm neonates that carries significant long-term implications for respiratory health. Its pathogenesis is multifactorial, with oxygen toxicity and injury from mechanical ventilation being key contributing factors. While neonatal animal models exposed to hyperoxia are widely used to mimic human BPD, lung development is often assessed through classical histological analyses. Although these methods remain fundamental in preclinical study, they may require multiple staining techniques and sections to highlight key features of BPD. Here, we introduce a label-free, multi-modal imaging platform combining two-photon excitation fluorescence (TPEF), second harmonic generation (SHG), and fluorescence lifetime imaging microscopy (FLIM) to characterize the lung alterations induced by a 7-day hyperoxia (95% O2) exposure in preterm rabbits.

methodsLung sections were obtained from preterm rabbit pups delivered at 28 gestational age (GA) (term 31 GA) either exposed to normoxia (21% O2) or hyperoxia (95% O2) for seven days. Lung sections were scanned with TPEF microscope at 780 nm and tissue intrinsic signals including autofluorescence intensity and lifetime, as well as SHG from collagen were simultaneously collected in the 470–570 nm, 420–460 nm and 380–410 nm ranges, respectively. BPD-relevant features were extracted from images, validated through traditional staining and immunolabelling and analyzed using an optimized pipeline. The tool reliability was tested by correlating label-free features with conventional Hematoxylin and eosin (H&E)-derived histomorphological parameters and lung functions measurements.

resultsThis method simultaneously resolves key BPD-related features, such as tissue density (TD%), alveolar exudates, collagen deposition, arterial medial thickness (MT%) alterations, and alveolar simplification, capturing the differences between hyperoxia and normoxia samples without dyes or antibodies. Quantitative outputs from our label-free pipeline strongly correlate with conventional histology and lung function measurements, thus validating its robustness.

conclusionThis approach holds promise as a powerful tool for preclinical research, enabling simultaneous imaging and quantification of multiple pathological features with a single acquisition. This tool is envisioned to be integrated with classical histology and immunolabelling for a more comprehensive and information rich assessment of tissue alterations.

Indexed as

Bronchopulmonary DysplasiaHyperoxiaLungMicroscopy, Fluorescence, MultiphotonAnimalsAnimals, NewbornDisease Models, AnimalFemaleRabbitsBronchopulmonary dysplasia (BPD)Fluorescence lifetime imaging microscopy (FLIM)HyperoxiaLabel-freePreterm rabbitSecond harmonic generation (SHG)Two-photon excitation fluorescence (TPEF)

Identifiers

PMID41742191
PMCPMC13040949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.